Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures

Area of Science:

• Neuroscience
• Cognitive Psychology
• Clinical Neurology

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder often associated with cognitive impairment.
• Assessing cognitive deficits and their progression in PD is crucial for patient management.
• Existing cognitive assessments may have limitations in detecting early deficits or tracking decline.

Purpose of the Study:

• To evaluate a computerized neuropsychological battery for assessing cognitive deficits in Parkinson's disease (PD).
• To compare the computerized battery's performance against conventional measures like the Montreal Cognitive Assessment (MoCA) and the Unified Parkinson's Disease Rating Scale (UPDRS).
• To determine the interrelationships between cognitive performance and factors such as age, education, and disease-specific symptoms.

Main Methods:

• A cohort of 37 PD patients and 47 controls underwent a computerized neuropsychological assessment at two time points, one year apart.
• Linear mixed-effects models were employed to analyze performance on computerized tasks.
• Conventional measures including the MoCA and UPDRS Part III were administered concurrently.

Main Results:

• The PD group exhibited significant deficits across all computerized tasks compared to controls at both assessment points.
• The MoCA only differentiated between groups at the one-year follow-up, but it successfully detected cognitive decline within the PD group over the year.
• Older age was the primary predictor of poorer performance on most tasks; UPDRS motor scores and other factors showed limited association with cognitive performance.

Conclusions:

• The computerized battery demonstrated superior sensitivity in detecting existing cognitive deficits in PD compared to the MoCA at baseline.
• The study raises questions about the current computerized battery's efficacy in tracking cognitive decline in PD over time, unlike the MoCA.
• Further refinement of computerized tools is needed for robust longitudinal assessment of cognitive changes in Parkinson's disease.